Skip to content

large-scale research infrastructure

Mining the secrets of lipid nanoparticles using research infrastructures

Robert Schnell is a scientist at Karolinska Institute focusing on development of novel antibiotic candidates. He has used both SciLifeLab and MAX IV laboratory infrastructures in a multifaceted project addressing the problem of infectious diseases in the context of the silent pandemic of antimicrobial resistance (AMR). 

Forskningsinfrastrukturernas centrala roll inom life science

Under senaste tid har forskningsinfrastrukturernas roll uppmärksammats och diskuterats flitigt. Betänkandet Stärkt fokus på framtidens forskningsinfrastruktur (SOU 2021:65) har besvarats med remissyttranden och Life Science kontoret har arrangerat årlig life science konferens.

The value of attending a course

Robert Schnell is a scientist at Karolinska Institute focusing on development of novel antibiotic candidates. He has used both SciLifeLab and MAX IV laboratory infrastructures in a multifaceted project addressing the problem of infectious diseases in the context of the silent pandemic of antimicrobial resistance (AMR). 

Antibiotic research pushed forward by use of large infrastructures

Robert Schnell is a scientist at Karolinska Institute focusing on development of novel antibiotic candidates. He has used both SciLifeLab and MAX IV laboratory infrastructures in a multifaceted project addressing the problem of infectious diseases in the context of the silent pandemic of antimicrobial resistance (AMR).